Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic

The COVID-19 pandemic forced the Dutch national breast screening program to a halt in week 12, 2020. In week 26, the breast program was resumed at 40% capacity, which increased to 60% in week 34. We examined the impact of the suspension and restart of the screening program on the incidence of screen...

Descripción completa

Detalles Bibliográficos
Autores principales: Eijkelboom, Anouk H., de Munck, Linda, Lobbes, Marc B.I., van Gils, Carla H., Wesseling, Jelle, Westenend, Pieter J., Guerrero Paez, Cristina, Pijnappel, Ruud M., Verkooijen, Helena M., Broeders, Mireille J.M., Siesling, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755636/
https://www.ncbi.nlm.nih.gov/pubmed/34217417
http://dx.doi.org/10.1016/j.ypmed.2021.106602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755636/
https://www.ncbi.nlm.nih.gov/pubmed/34217417
http://dx.doi.org/10.1016/j.ypmed.2021.106602

Ejemplares similares